Sino Biopharmaceutical (Sino Biopharmaceutical) Accounts Payable : $298 Mil (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Accounts Payable?

Sino Biopharmaceutical's Accounts Payable for the quarter that ended in Jun. 2023 was $298 Mil.

Sino Biopharmaceutical's quarterly Accounts Payable declined from Jun. 2022 ($400 Mil) to Dec. 2022 ($235 Mil) but then increased from Dec. 2022 ($235 Mil) to Jun. 2023 ($298 Mil).

Sino Biopharmaceutical's annual Accounts Payable declined from Dec. 2020 ($298 Mil) to Dec. 2021 ($266 Mil) and declined from Dec. 2021 ($266 Mil) to Dec. 2022 ($235 Mil).

Sino Biopharmaceutical Accounts Payable Historical Data

The historical data trend for Sino Biopharmaceutical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Accounts Payable Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

257.99

297.86

265.83

234.86

186.93

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															265.83	399.76	234.86	298.44	186.93

Sino Biopharmaceutical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Sino Biopharmaceutical Accounts Payable Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SBHMY:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.